Outdated assessment of treatment response makes good cancer drugs look bad

Tumor shrinkage is not the only measure of a successful anti-cancer therapy. A University of Colorado Cancer Center article published in the journal Frontiers in Oncologydescribes a promising alternative: metabolic imaging. Tumors rush their metabolism to grow and proliferate. By recognizing a drug’s ability to stop this energy overuse, doctors may be able to determine […]

Read the whole article on Science Blog

More from Science Blog